AKTX
Price
$0.78
Change
-$0.01 (-1.27%)
Updated
Sep 15, 04:49 PM (EDT)
Capitalization
25.73M
DSGN
Price
$5.87
Change
-$0.17 (-2.82%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
343.4M
51 days until earnings call
Interact to see
Advertisement

AKTX vs DSGN

Header iconAKTX vs DSGN Comparison
Open Charts AKTX vs DSGNBanner chart's image
Akari Therapeutics
Price$0.78
Change-$0.01 (-1.27%)
Volume$3.92K
Capitalization25.73M
Design Therapeutics
Price$5.87
Change-$0.17 (-2.82%)
Volume$1.97K
Capitalization343.4M
AKTX vs DSGN Comparison Chart in %
Loading...
AKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKTX vs. DSGN commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKTX is a Hold and DSGN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (AKTX: $0.79 vs. DSGN: $6.03)
Brand notoriety: AKTX and DSGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKTX: 44% vs. DSGN: 93%
Market capitalization -- AKTX: $25.73M vs. DSGN: $343.4M
AKTX [@Biotechnology] is valued at $25.73M. DSGN’s [@Biotechnology] market capitalization is $343.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKTX’s FA Score shows that 1 FA rating(s) are green whileDSGN’s FA Score has 0 green FA rating(s).

  • AKTX’s FA Score: 1 green, 4 red.
  • DSGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both AKTX and DSGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKTX’s TA Score shows that 4 TA indicator(s) are bullish while DSGN’s TA Score has 4 bullish TA indicator(s).

  • AKTX’s TA Score: 4 bullish, 3 bearish.
  • DSGN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AKTX is a better buy in the short-term than DSGN.

Price Growth

AKTX (@Biotechnology) experienced а -3.63% price change this week, while DSGN (@Biotechnology) price change was -6.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.74%. For the same industry, the average monthly price growth was +7.59%, and the average quarterly price growth was +34.47%.

Reported Earning Dates

DSGN is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSGN($343M) has a higher market cap than AKTX($25.7M). DSGN YTD gains are higher at: -2.269 vs. AKTX (-35.328). AKTX has higher annual earnings (EBITDA): -11.97M vs. DSGN (-74.31M). DSGN has more cash in the bank: 216M vs. AKTX (2.71M). AKTX has less debt than DSGN: AKTX (1.55M) vs DSGN (1.95M). AKTX (0) and DSGN (0) have equivalent revenues.
AKTXDSGNAKTX / DSGN
Capitalization25.7M343M7%
EBITDA-11.97M-74.31M16%
Gain YTD-35.328-2.2691,557%
P/E RatioN/AN/A-
Revenue00-
Total Cash2.71M216M1%
Total Debt1.55M1.95M79%
FUNDAMENTALS RATINGS
AKTX: Fundamental Ratings
AKTX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKTXDSGN
RSI
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
75%
Bullish Trend 11 days ago
88%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARRNF0.22N/A
+1.01%
American Rare Earths Ltd.
CTYP6.18N/A
N/A
Community Bankers (PA)
SNMSF16.13N/A
N/A
SPIN MASTER CORP
GOFPY11.32-0.04
-0.35%
Greek Organisation of Football Prognostics SA
ISNPY38.70-0.16
-0.41%
Intesa Sanpaolo S.p.A.

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with IDYA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
+1.17%
IDYA - DSGN
50%
Loosely correlated
-1.28%
VRDN - DSGN
49%
Loosely correlated
-3.97%
AURA - DSGN
48%
Loosely correlated
-6.93%
CRNX - DSGN
48%
Loosely correlated
+0.80%
DYN - DSGN
47%
Loosely correlated
-0.19%
More